home / stock / avte / avte news


AVTE News and Press, Aerovate Therapeutics Inc. From 07/07/21

Stock Information

Company Name: Aerovate Therapeutics Inc.
Stock Symbol: AVTE
Market: NASDAQ
Website: aerovatetx.com

Menu

AVTE AVTE Quote AVTE Short AVTE News AVTE Articles AVTE Message Board
Get AVTE Alerts

News, Short Squeeze, Breakout and More Instantly...

AVTE - Last IPO Week Was The Busiest In Over a Decade

We have witnessed a record last week, with 19 launched IPOs and almost $10 billion raised. That is the most companies in one week since 2004. Even more, the NYSE floor which has been rather quiet in the past year came back to life. SPACs have been favored for a good part of 2020 and the beg...

AVTE - A Shortened IPO Holiday Week

Last week turned out to be the busiest IPO week since 2004. Nearly $10 billion was raised in 19 public offerings. DiDi Global (NYSE: DIDI), a Chinese ride-hailing app with 15 million drivers across 4,000 towns and cities, led the way by raising $4.4 billion at a $70.4 billion market cap. Se...

AVTE - U.S. IPO Weekly Recap: DiDi Leads A 19 IPO Week, The Busiest Since 2004

In the US IPO market’s busiest week since 2004, 19 IPOs raised nearly $10 billion, led by Chinese ride-hailing giant DiDi Global. Cybersecurity platform SentinelOne (S) upsized and priced above the upwardly revised range to raise $1.2 billion at a $10.6 billion market cap....

AVTE - Aerovate closes upsized $140M IPO

Aerovate Therapeutics ([[AVTE]] +2.7%) has closed its upsized $139.8M IPO.The IPO of 9,984,463 shares was set at $14 per share. This included the underwriters' option to purchase 1,302,321 shares.Jefferies, Cowen, and Evercore were joint book-runners. Wedbush was lead manager.Shares bega...

AVTE - Aerovate Therapeutics Announces Closing of Initial Public Offering with Exercise in Full of the Underwriters' Option to Purchase Additional Shares

BOSTON, July 02, 2021 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced the closing of its upsized initial ...

Previous 10 Next 10